Literature DB >> 16401166

Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.

Koh Iwasaki, Masahiro Maruyama, Naoki Tomita, Katsutoshi Furukawa, Miyako Nemoto, Hironori Fujiwara, Takashi Seki, Masahiko Fujii, Manabu Kodama, Hiroyuki Arai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16401166     DOI： 10.4088/jcp.v66n1219a

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  19 in total

1.  The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan.

Authors:  Sachiko Imamura; Masahiro Tabuchi; Hirotaka Kushida; Akinori Nishi; Hitomi Kanno; Takuji Yamaguchi; Kyoji Sekiguchi; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2011-03-26       Impact factor: 5.046

2.  Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).

Authors:  Tsuyoshi Miyaoka; Motohide Furuya; Jun Horiguchi; Rei Wake; Sadayuki Hashioka; Masaya Tohyama; Norio Mori; Yoshio Minabe; Masaomi Iyo; Shyuichi Ueno; Sachiko Ezoe; Kenta Murotani; Syuzo Hoshino; Haruo Seno
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

3.  Isoliquiritigenin is a novel NMDA receptor antagonist in kampo medicine yokukansan.

Authors:  Zenji Kawakami; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2011-06-21       Impact factor: 5.046

4.  Hypnotic activities of Zao Ren An Shen capsule, a traditional Chinese medicine, in an anxiety-like mouse model.

Authors:  Tian-Xiao Wang; Hao-Hua Wei; Ze-Ka Chen; Wei-Min Qu; Zhi-Li Huang
Journal:  Sleep Breath       Date:  2020-11-16       Impact factor: 2.816

5.  Effects of geissoschizine methyl ether, an indole alkaloid in Uncaria hook, a constituent of yokukansan, on human recombinant serotonin 7 receptor.

Authors:  Toshiyuki Ueki; Akinori Nishi; Sachiko Imamura; Hitomi Kanno; Kazushige Mizoguchi; Kyoji Sekiguchi; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2012-09-12       Impact factor: 5.046

6.  An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.

Authors:  Taku Hatano; Nobutaka Hattori; Tadaaki Kawanabe; Yasuo Terayama; Norihiro Suzuki; Yasuo Iwasaki; Toshiki Fujioka
Journal:  J Neural Transm (Vienna)       Date:  2013-10-30       Impact factor: 3.575

7.  Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia.

Authors:  Yuen-Shan Ho; Kwok-Fai So; Raymond Chuen-Chung Chang
Journal:  Chin Med       Date:  2011-04-22       Impact factor: 5.455

8.  Yokukansan improves distress of medical staff, and cognitive function and motivation in patients with destructive and aggressive behaviors after traumatic brain injury.

Authors:  Tomomichi Kan'o; Jing-Yan Han; Kuniaki Nakahara; Shingo Konno; Mayuko Shibata; Takao Kitahara; Kazui Soma
Journal:  Acute Med Surg       Date:  2014-03-05

9.  Yi-gan san restores behavioral alterations and a decrease of brain glutathione level in a mouse model of schizophrenia.

Authors:  Manabu Makinodan; Takahira Yamauchi; Kouko Tatsumi; Hiroaki Okuda; Yoshinobu Noriyama; Miyuki Sadamatsu; Toshifumi Kishimoto; Akio Wanaka
Journal:  J Brain Dis       Date:  2009-02-12

10.  Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study.

Authors:  Tsuyoshi Miyaoka; Rei Wake; Motohide Furuya; Kristian Liaury; Masa Ieda; Kazunori Kawakami; Keiko Tsuchie; Takuji Inagaki; Jun Horiguchi
Journal:  BMC Psychiatry       Date:  2012-11-29       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.